The FDA has recently been active, but the impact of this activity is unclear due to ongoing regulatory uncertainty. The situation suggests that the FDA's actions are taking place in an environment where rules and guidelines are not well established. The outcome of the FDA's activity is uncertain as a result of this regulatory uncertainty.